Evidence map›Paper›PMID 30013113›Full record

ArticleCell death & disease2018

Correction: DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residues.

Valérie Glorian, Jennifer Allègre, Jean Berthelet, Baptiste Dumetier, Pierre-Marie Boutanquoi, Nathalie Droin, Cémile Kayaci, Jessy Cartier, Simon Gemble, Guillaume Marcion and 6 more

Abstract readPublished Erratum
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Valérie GlorianUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Jennifer AllègreUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Jean BertheletUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Baptiste DumetierUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Pierre-Marie BoutanquoiUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Nathalie DroinInserm U1170, Gustave Roussy, Villejuif, France.
Cémile KayaciUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Jessy CartierUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Simon GembleUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Guillaume MarcionUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Daniel GonzalezUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Romain BoidotUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Carmen GarridoUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Olivier MicheauUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Eric SolaryInserm U1170, Gustave Roussy, Villejuif, France.
Laurence DubrezUniversité de Bourgogne Franche-Comté, LNC UMR1231, Dijon, France. ldubrez@u-bourgogne.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Correction to:Cell Death & Disease8, e2816 (2017); https://doi.org/10.1038/cddis.2017.222 ; published online 25 May 2017.

Identifiers

PMID30013113
PMCPMC6048045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.